Evercore ISI analyst Elizabeth Anderson lowered the firm’s price target on Hinge Health (HNGE) to $45 from $50 and keeps an Outperform rating on the shares. The firm made several price target adjustments and additions to the firm’s Tactical call lists as part of the firm’s healthcare technology and distribution preview for Q1.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Hinge Health reports support for over 300 public sector organizations
- Hinge Health price target raised to $55 from $50 at RBC Capital
- Tiger Global exits ModoDB position, cuts stakes in Microsoft, Meta, Reddit
- Hinge Health Earnings Call Signals Profitable Growth Path
- Hinge Health price target lowered to $55 from $70 at KeyBanc